IMMUNOTHERAPY BRIDGE 2018 AND MELANOMA BRIDGE 2018: MEETING ABSTRACTS

J Transl Med 2019, 17(Suppl 1):16

 

 2018

---

 

PERSPECTIVES IN IMMUNOTHERAPY: MEETING REPORT FROM THE IMMUNOTHERAPY BRIDGE, Napoli, November 29^th-30^th 2017

Ascierto P.A., Brugarolas J., Buonaguro L., Butterfield L.H., Carbone D., Daniele B., Ferris R., Fox B.A., Galon J., Gridelli C., Kaufman H.L., Klebanoff C.A., Melero I., Nathan P., Paulos C.M., Ruella M., Sullivan R., Zarour H. and  Puzanov I.

Ascierto et al. Journal for ImmunoTherapy of Cancer (2018) 6:69

PERSPECTIVES IN MELANOMA: MEETING REPORT FROM THE "MELANOMA BRIDGE", Napoli, November 30^thndDecember 2^nd 2017

Ascierto P.A., Puzanov I., Agarwala S.S., Bifulco C. , Botti G., Caracò C., Ciliberto G. , Davies M.A., D/wp-content/uploads/Great-Debate-jtm.pdfummer R., Ferrone S., Gajewski T.F., Garbe C., Luke J.J., Marincola F.M., Masucci G., Mehnert J.M., Mozzillo N., Palmieri G., Postow M.A., Schoenberger S.P., Wang E., Thurin M.

Journal: Ascierto et al. J Transl Med (2018) 16:207

THE GREAT DEBATE AT “MELANOMA BRIDGE", Napoli, December 2nd, 2017

Ascierto P.A., Caracò C., Gershenwald J.E., Hamid O., Ross M., Sullivan R.J., Puzanov I.

Journal: Ascierto et al. J Transl Med (2018) 16:101

IMMUNOTHERAPY AND MELANOMA BRIDGE 2017 MEETING ABSTRACTS

J Transl Med 2018, 16(Suppl 1):4

 

 

 2017

---

 

"FUTURE PERSPECTIVES IN MELANOMA RESEARCH "MELANOMA BRIDGE", NAPOLI, NOVEMBER 30TH-3RD DECEMBER 2016

Ascierto P.A., Agarwala S.S., Ciliberto G., Demaria S., Dummer R., Duong C.P.M., Ferrone S., Formenti S.C., Garbe C., Halaban R., Khleif S., Luke J.J., Mir L.M., Overwijk W.W., Postow P., Puzanov I.,  Sondel P., Taube J.M., Straten P.T., Stroncek D.F., Wargo J.A., Zarour H., Thurin M.

Journal: Ascierto et al. J Transl Med (2017) 15:236

LE MALATTIE RARE IN ITALIA FOCUS SU EMOFILIA B

Source: www.pharmastar.it

 

PERSPECTIVES IN IMMUNOTHERAPY: MEETING REPORT FROM THE “IMMUNOTHERAPY BRIDGE”, NAPOLI, NOVEMBER 30TH 2016

Ascierto P.A., Daniele B., Hammers H., Hirsh V., Kim J., Licitra L., Nanda R., Pignata S.

Journal: Ascierto et al. J Transl Med (2017) 15:205

 

WORLD-WIDE IMMUNOSCORE TASK FORCE: MEETING REPORT FROM THE “MELANOMA BRIDGE”, NAPOLI, NOVEMBER 30TH–DECEMBER 3RD, 2016

Galon J., Lugli A., Bifulco C., Pages F., Masucci G., Marincola F.M., Ascierto P.A.

Journal: Galon et al. J Transl Med (2017) 15:212 

 

PRIMARY BILIARY CHOLANGITIS: ADVANCES IN MANAGEMENT AND TREATMENT OF THE DISEASE

Invernizzi P, Floreani A, Carbone M, Marzioni M, Craxi A, Muratori L, Vespasiani Gentilucci U, Gardini I, Gasbarrini A, Kruger P, Mennini FS, Ronco V, Lanati EP, Canonico PL, Alvaro D

Journal: Dig Liver Dis. 2017 May;S1590-8658(17)30857-5

 

IMMUNOTHERAPY AND MELANOMA BRIDGE 2016 MEETING ABSTRACTS

J Transl Med 2017, 15(Suppl 1):8

 

 

 2016

---

 

SIXTH WORKSHOP ON ECONOMICS AND DRUGS IN HEPATOLOGY (WEF E 2016)

Greco A.V., Gasbarrini A. Guest Editors: Gasbarrini A., Cicchetti A.

Eur Rev Med Pharmacol Sci 2016; 20 (1 Suppl)

 

IMMUNOTHERAPY AND MELANOMA BRIDGE 2015 MEETING ABSTRACTS

J Transl Med 2016, 14(Suppl 1):S65

 

IMMUNOSCORE AND IMMUNOPROFILING IN CANCER: AN UPDATE FROM THE MELANOMA AND IMMUNOTHERAPY BRIDGE 2015

Galon J., Fox B.A., Bifulco C.B., Masucci G., Rau T., Botti G., Marincola F.M., Ciliberto G., Pages F., Ascierto P.A. and Capone M.

Galon et al. J Transl Med (2016) 14:273

 

FUTURE PERSPECTIVES IN MELANOMA RESEARCH. MEETING REPORT FROM THE "MELANOMA BRIDGE. NAPOLI, DECEMBER 1st-4th 2015"

Ascierto P.A., Agarwala S., Botti G., Cesano A., Ciliberto G., Davies M.A., Demaria S., Dummer R., . Eggermont A.M., Ferrone S., Xin Fu Y., Gajewski T.F., Garbe C., Huber V., Khleif S., Krauthammer M., Lo R.S., Masucci G., Postow M., Puzanov I., Silk A., Spranger S., Stroncek D.F., Tarhini A., Taube J., Testori A., Wang E., Wargo J.A., Yee C., Zarour H., Zitvogel L., Fox B.A., Mozzillo N., Marincola F.M. and  Thurin M.

Ascierto et al. J Transl Med (2016) 14:313

 

PERSPECTIVES IN IMMUNOTHERAPY: MEETING REPORT FROM THE "IMMUNOTHERAPY BRIDGE" , NAPOLI, DECEMBER 5th 2015

Ascierto P.A., Ascierto M.L., Formenti S., Gnjatic R., Hammers H., Hirsh V., Kiessling V., Melero I., Nanda R., Pawelec G., Pignata S., Romero P., Speiser D.E., Fox B.A. and Marincola F.M.

Ascierto et al. Journal for ImmunoTherapy of Cancer (2016) 4:62

 

 

 

 2015

---

 

FUTURE PERSPECTIVES IN MELANOMA RESEARCH. MEETING REPORT FROM THE "MELANOMA BRIDGE. NAPOLI, DECEMBER 3rd-6th 2014"

Ascierto P.A., Atkins M., Bifulco C., Botti G., Cochran A., Davies M., Demaria S., Dummer R., Ferrone S., Formenti S., Gajewski T.F., Garbe C., Hodi F.S., Khleif S., Kiessling R., Lo R., Lorigan P., Mc Arthur G., Masucci G., Melero I., Mihm M., Palmieri G., Parmiani G., Puzanov I., Romero P., Schilling B., Seliger B., Stroncek D., Taube J., Tomei S., Zarour H.M., Testori A., Wang E., Galon J., Ciliberto G., Mozzillo N., Marincola F.M. and  Thurin M.

Ascierto et al. J Transl Med (2015) 13:374

 

MELANOMA BRIDGE 2014 MEETING ABSTRACTS 

Journal of Translational Medicine 2015, Volume 13 Suppl 1

 

 

 

2014

---

 

FUTURE PERSPECTIVES IN MELANOMA RESEARCH. MEETING REPORT FROM THE "MELANOMA BRIDGE. NAPOLI, DECEMBER 5th-8th 2013"

Ascierto P.A., Grimaldi A.M., Carrizosa Anderson A., Bifulco C., Cochran A., Garbe C., Eggermont A.M., Faries M., Ferrone S., Gershenwald J.E., Gajewski T.F., Halaban R., Hodi F.S., Kefford R., Kirkwood J.M., Larkin J., Lo R.S., Leachman S., Maio M., Marais R., Masucci G., Melero I., Palmieri G., Puzanov I., Ribas A., Saenger Y., Schilling B., Seliger B., Stroncek D., Sullivan R., Testori A., Wang E., Ciliberto G., Mozzillo N., Marincola F.M. and Thurin M.

Ascierto et al. Journal of Translational Medicine 2014, 12:277

 

MELANOMA BRIDGE 2013: POSTER AND ORAL PRESENTATIONS

Journal of Translational Medicine 2014, Volume 12 Suppl 1

 

 

 

 2013

---

 

FUTURE PERSPECTIVES IN MELANOMA RESEARCH. MEETING REPORT FROM THE "MELANOMA BRIDGE. NAPOLI, DECEMBER 2ND-4TH 2012"

Ascierto P.A., Grimaldi A.M., Acquavella N., Borgognoni L., Calabrò L., Cascinelli N., Cesano A., Del Vecchio M., Eggermont A.M., Faries M., Ferrone S., Fox B.A., Gajewski T.F., Galon J., Gnjatic S., Gogas H., Kashani-Sabet M., Kaufman H.L., Larkin J., Lo R.S., Mantovani A., Margolin K., Melief C., McArthur G., Palmieri G,, Puzanov I., Ribas A., Seliger B., Sosman J., Suenaert P., Tarhini A.A., Trinchieri G., Vidal-Vanaclocha F., Wang E., Ciliberto G., Mozzillo N., Marincola F.M. and Thurin M.

Ascierto et al. Journal of Translational Medicine 2013, 11:137

 

CROHN'S DISEASE: AN ECONOMIC ASSESSMENT OF BIOLOGICAL DRUGS IN ITALY

Cicchetti A., Gasbarrini A., Ruggeri M. and the WEF study group.

Poster PGI 29 - Dublino, ISPOR 16th European Congress. 2013.

 

HEPATOCELLULAR CARCINOMA: AN EPIDEMIOLOGICAL AND MANAGEMENT SURVEY-BASED ANALYSIS IN ITALY

Cicchetti A., Gasbarrini A., Ruggeri M., Sacchini D. and the WEF studymgroup.

Poster PGI 8 - Dublino, ISPOR 16th European Congress. 2013.

 

WORKSHOP IN PHARMACOECONOMICS: AN ITALIAN EXPERIENCE OF MULTI-STAKEHOLDER HTA CONSENSUS 

Cicchetti A., Gasbarrini A., Ruggeri M., Sacchini D., Lanati E.P. and the WEF study group.

Poster PHP 159 - Dublino, ISPOR 16th European Congress. 2013.

 

HOW THE PRICING STRATEGY OF 2ND GENERATION HCV DIRECT ANTIVIRAL AGENTS CAN AFFECT THE NUMBER OF TREATED PATIENTS IN ITALY AND THE NATIONAL DRUG BUDGE

Lanati E.P., Lidonnici D., Cammà C. and the WEF study group.

Poster PGI 47 - Dublino, ISPOR 16th European Congress. 2013.

 

COST-EFFECTIVENESS OF SORAFENIB TREATMENT IN FIELD PRACTICE FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA

Camma C., Calibbo G., Petta S., Enea M., Iavarone M., Grieco A., Gasbarrini A., Villa E., Zavaglia C., Bruno R., Colombo M., Craxì A., WEF study group and the SOFIA study group.

Hepatology. 2013 Mar;57(3):1046-54

 

CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) — EXPLANATION AND ELABORATION: A REPORT OF THE ISPOR HEALTH ECONOMIC EVALUATION PUBLICATION GUIDELINES GOOD REPORTING PRACTICES TASK FORCE ELENA PAOLA LANATI - REVIEWER

Husereau D., Drummond M., Petrou S., Carswell C., MSc, Moher D., Greenberg D., Augustovski F., H. Briggs A., Mauskopf J., Loder E., on behalf of the ISPOR Health Economic Evaluation Publication Guidelines - CHEERS Good Reporting Practices Task Force

VALUE IN HEALTH 16 ( 2013 ) 231 –250

 

 

 

 2012

---

 

THE ROLE OF BRAF V600 MUTATION IN MELANOMA

Ascierto P.A., Kirkwood J.M., Grob J.J., Simeone E., Grimaldi A.M., Maio M., Palmieri G., Testori A., Marincola F.M. and Mozzillo N.

Journal of Translational Medicine. 2012.

 

EFFECT OF DISCOUNTING ON ESTIMATION OF BENEFITS DETERMINED BY HEPATITIS C TREATMENT

Messori A., Fadda V., Maratea D., Trippoli S.

World J Gastroenterol. 2012.